Literature DB >> 22395573

Relationship between some clinical situations, autoantibodies, and pseudothrombocytopenia.

Ayse Isik1, Ozlem Sahin Balcik, Derya Akdeniz, Handan Cipil, Sema Uysal, Ali Kosar.   

Abstract

The widespread usage of blood count autoanalyzers has led to a major improvement in cellular hematology because of quick and accurate results found in most instances. However, spurious test results also can be observed like pseudothrombocytopenia (PTCP). In our study, we aimed to evaluate the clinical and laboratory factors associated with PTCP. Forty-six patients with PTCP and 69 healthy volunteers were enrolled in the study. Sex distribution was similar between the groups. Hospitalization, infection, the use of low-molecular-weight heparin and pregnancy increased the incidence of PTCP. Atherosclerosis and some drugs such as warfarin and calcium channel blockers were associated with PTCP, but the coincidence was not statistically significant. Antinuclear antibody positivity was higher in PTCP group (18.8% vs 7.2%; P=0.033) but anticardiolipin positivity rates were similar when compared to controls. Pseudothrombocytopenia was frequently misdiagnosed, which led to inappropiate treatments. Therefore, this situation should be kept in mind.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22395573     DOI: 10.1177/1076029611434525

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  5 in total

1.  Assessment of Platelet-to-Lymphocyte Ratio Can Be Affected by Several Factors.

Authors:  Mustafa Gulgun
Journal:  Med Princ Pract       Date:  2017-01-23       Impact factor: 1.927

Review 2.  Clinical Utility of Blood Cell Histogram Interpretation.

Authors:  E T Arun Thomas; S Bhagya; Abdul Majeed
Journal:  J Clin Diagn Res       Date:  2017-09-01

3.  Analysis of platelet-to-lymphocyte ratio requires methodological consideration.

Authors:  Mustafa Gülgün
Journal:  Anatol J Cardiol       Date:  2017-02       Impact factor: 1.596

4.  An Episode of Pseudothrombocytopenia during Pembrolizumab Therapy in NSCLC Patient.

Authors:  Kinga Krukowska; Robert Kieszko; Katarzyna Kurek; Izabela Chmielewska; Paweł Krawczyk; Janusz Milanowski
Journal:  Case Rep Oncol Med       Date:  2020-05-08

Review 5.  Pseudothrombocytopenia-A Review on Causes, Occurrence and Clinical Implications.

Authors:  Benjamin Lardinois; Julien Favresse; Bernard Chatelain; Giuseppe Lippi; François Mullier
Journal:  J Clin Med       Date:  2021-02-04       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.